Advanced Filters
noise

Minatoga, Japan Clinical Trials

A listing of Minatoga, Japan clinical trials actively recruiting patients volunteers.

Found 64,772 clinical trials
G Gustaf Hellspong, MD, PhD Student

Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy

Randomized, placebo-controlled, double-blinded, parallel group clinical trial to investigate if 6 months of oral lithium tablets (S-lithium 0,5-1,0 mmol/l) will prevent cognitive decline after brain radiotherapy in pediatric brain tumor survivors. Primary outcome measure is Processing Speed Index (PSI) 2 years after start of study treatment.

5 years of age All Phase 2
R Regina Swift, RN

Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma

This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who currently show progressive disease using BCMA to test progression.

18 years of age All Phase N/A
y yang liu

First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy

This is an open-label, single arm Phase II study designed to observe and evaluate the efficacy and safety of sequential thoracic radiotherapy in the first-line treatment of extensive small cell lung cancer with chemotherapy combined with approved PD-1/PD-L1 inhibitors.

18 - 75 years of age All Phase 2

Effect of Blood Flow Restriction Technique After Anterior Cruciate Ligament Reconstruction

The purpose of this study will be to evaluate the effect of adding BFR (using 80% of LOP) to the conventional physical therapy program on knee function, functional test, balance, quadriceps and hamstrings muscles strength, thigh muscle girth and knee effusion in rehabilitation after ACLR.

18 - 35 years of age All Phase N/A
L Leyla ERASLAN, Prof

Knee Extension Deficit Following an Anterior Cruciate Ligament Reconstruction (Extension Loss)

Knee extension loss following an anterior cruciate ligament (ACL) reconstruction is believed to play an important role in quadriceps strength recovery. One of the main goals of the rehabilitation following ACL reconstruction is to restore knee extensor muscle strength. Deficits of more than a five-degree extension range of motion (ROM) …

18 - 45 years of age All Phase N/A

Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates

This study is an open-label drug-drug interaction (DDI) study of ZYN002 transdermal gel and multiple drugs.

18 - 55 years of age All Phase 1
X Xiang Y Zhang, M.D.,Ph.D

The Therapeutic Mechanism of Compassion-Based Family Intervention

To investigate the correlations between self-compassion-related variables in parents of adolescents with emotional disorders and parenting stress as well as self-stigmatization; and the correlations between self-compassion-related variables and the severity of depressive and anxiety symptoms in adolescents. To evaluate the effectiveness of a Compassion-Focused Family Intervention in increasing self-compassion among …

12 - 18 years of age All Phase N/A
Q Qianqian Xu, RCMP

CHM for Female Stress Urinary Incontinence

This single-arm, open-label pilot clinical trial will test the hypothesis that S-2196, a Chinese herbal medicine formula, will show efficacy and safety in alleviating the amount and frequency of urinary incontinence in female individuals with stress urinary incontinence. All participants (n=15) will receive 1 week of screening, 2 weeks of …

55 years of age Female Phase N/A
E Edith Jimenez

Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)

The proposed project aims to test the cognitive and neural effects of a cognitive training in a sample of individuals seeking treatment for anxiety, depression, or traumatic stress symptoms. Participants will be randomly assigned to one of two groups. Group 1 will receive a computer-based program that is designed as …

21 - 55 years of age All Phase 2/3
J Jinji Yang, MD

Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.

Efficacy and Safety Evaluation of Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.

18 years of age All Phase 2

Simplify language using AI